封面
市場調查報告書
商品編碼
1593521

乳房重建市場規模、佔有率和成長分析(按產品、按程序、按類型、最終用戶、按地區):產業預測(2024-2031)

Breast Reconstruction Market Size, Share, Growth Analysis, By Product (Breast Implant, Tissue Expander), By Procedure (Immediate Procedures, Delayed Procedures), By Type, By End Use, By Region - Industry Forecast 2024-2031

出版日期: | 出版商: SkyQuest | 英文 155 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

2022年全球乳房重建市場規模約為5.491億美元,預計將從2023年的5.864億美元增加至2031年的9.926億美元,2017年的複合年成長率為6.8。

由於乳癌發病率上升和支持性報銷政策,全球乳房重建市場正在顯著成長。由於技術進步和乳房重建手術的增加,市場前景仍然樂觀。特別是,醫療保險可以報銷乳癌乳房切除術後的乳房重建手術,澳洲服務局根據外部乳房人工替代物報銷計畫報銷乳房人工替代物。這些支持措施預計將進一步增強市場動態。主要參與企業正在積極回應,透過推出創新產品、推出意識計劃和擴大地理覆蓋範圍來滿足日益成長的乳房重建需求。乳房重建意識日由整形外科基金會和美國整形外科醫生協會於 2023 年 10 月主辦,旨在傳播重要訊息並提高被診斷患有乳癌的女性對乳房重建方案的認知。同樣,2021 年 10 月,Sientra, Inc. 與 Mission Plastico 合作推出了「重塑生活」計畫:為貧困女性提供免費的乳房切除後乳房重建服務,這是一項旨在實現的慈善活動。隨著這些努力的持續,由於患者需求的增加和乳癌倖存者資源的增加,乳房重建市場有望顯著成長。

目錄

介紹

  • 分析目的
  • 定義
  • 市場範圍

分析方法

  • 資訊採購
  • 二手資料來源和主要資料來源
  • 市場規模預測
  • 市場假設與限制

執行摘要

  • 市場概況及展望
  • 供需趨勢分析
  • 按細分市場的機會分析

市場動態及展望

  • 市場動態
    • 促進因素
    • 機會
    • 抑制因素
    • 任務
  • 波特的分析

主要市場考察

  • 關鍵成功因素
  • 競爭程度
  • 主要投資機會
  • 創新矩陣
  • 市場生態系統
  • 監管環境
  • 技術分析
  • 專利分析
  • PESTEL分析
  • 市場魅力指數(2023)

乳房重建市場:依產品

  • 市場概況
  • 乳房植入
    • 矽膠植入
    • 圓形的
    • 解剖學的
    • 生理食鹽水植入
    • 圓形的
    • 解剖學的
  • 組織擴張器
    • 生理食鹽水擴張器
    • 氣動組織擴張器
  • 去細胞真皮基材

乳房重建市場:依程序分類

  • 市場概況
  • 同步重組治療
  • 延遲重組治療
  • 再植手術

乳房重建市場:依類型

  • 市場概況
  • 單側乳房重建
  • 兩個乳房

乳房重建市場:依最終用戶分類

  • 市場概況
  • 醫院/診所
  • 門診手術中心
  • 其他

乳房重建市場:按地區

  • 市場概況
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲
  • 中東和非洲 (MEA)
    • 波灣合作理事會(GCC) 國家
    • 南非
    • 其他中東/非洲

競爭格局

  • 前5名企業對比
  • 主要企業市場定位(2023年)
  • 主要市場參與者所採取的策略
  • 近期市集活動
  • 主要企業市場佔有率(2023年)

主要企業簡介

  • 強生公司(美國)
  • 艾爾建美學 (AbbVie)(美國)
  • Ideal Implant 公司(美國)
  • 賽賓(法國)
  • GC美學(愛爾蘭)
  • POLYTECH 健康與美容(德國)
  • 西恩特拉(美國)
  • Integra生命科學公司(美國)
  • RTI Surgical Holdings(美國)
  • 建立實驗室 SA(美國)
  • 西利梅德(巴西)
  • Arion實驗室(法國)
  • 廣州萬和塑膠原料有限公司 (中國)
  • CEREPLAS(法國)
  • 漢斯生物醫學(韓國)
  • PMT公司(美國)
  • 上海康寧醫療器材(中國)
  • 貝德米斯(美國)
  • Surgiform 科技有限公司(美國)
  • Motiva 植體(哥斯大黎加)
簡介目錄
Product Code: SQMIG35A2947

Global Breast Reconstruction Market size was valued at around USD 549.1 Million in 2022 and is expected to rise from USD 586.4 Million in 2023 to reach a value of USD 992.6 Million by 2031, at a CAGR of 6.8% over the forecast period (2024-2031).

The Global Breast Reconstruction market is experiencing significant growth driven by the rising incidence of breast cancer and supportive reimbursement policies. With technical advancements and an increasing number of breast reconstruction surgeries, the market outlook remains positive. Notably, Medicare provides reimbursement for breast reconstruction surgeries following mastectomies due to breast cancer, while Services Australia offers compensation for breast prostheses under its external breast prosthesis reimbursement scheme. These supportive initiatives are expected to enhance market dynamics further. Major industry players are actively responding by launching innovative products, rolling out awareness programs, and expanding their geographical reach to meet the surging demand for breast reconstruction. A prime example includes the Breast Reconstruction Awareness Day initiative organized by The Plastic Surgery Foundation and The American Society of Plastic Surgeons in October 2023, which aimed to raise awareness and disseminate vital information about breast reconstruction options for women diagnosed with breast cancer. Similarly, in October 2021, Sientra, Inc. collaborated with Mission Plasticos to launch "Reshaping Lives: Full Circle," a philanthropic initiative aimed at providing free post-mastectomy breast reconstruction services for underprivileged women. As these efforts continue, the Breast Reconstruction market is poised for substantial growth, fueled by both increasing patient needs and enhanced resource availability for breast cancer survivors.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Breast Reconstruction market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Breast Reconstruction Market Segmental Analysis

Global Breast Reconstruction Market is segmented by Product, Procedure, Type, End User, and region. Based on Product, the market is segmented into Breast Implant (Silicone Implants, Saline Implants), Tissue Expander (Saline Tissue Expander, Air Tissue Expander), Acellular Dermal Matrix. Based on Procedure, the market is segmented into Immediate Procedures, Delayed Procedures, Revision Procedures. Based on Type, the market is segmented into Unilateral Breast Reconstruction, and Bilateral. Based on End User, the market is segmented into Hospitals & Clinics, Ambulatory Surgical Centers, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Breast Reconstruction Market

A significant market driver for the global breast reconstruction market is the heightened focus on aesthetic outcomes following surgeries such as mastectomies. As awareness among patients of the advantages and availability of reconstructive surgery increases, so does demand. Advances in surgical techniques have made breast reconstruction more acceptable and accessible, bolstered by media campaigns and educational initiatives. The rising incidence of breast cancer further intensifies the need for such reconstructive options. Moreover, societal acceptance of cosmetic improvements fuels this growth, as patients increasingly seek not only health restoration but also enhanced physical appearance, positioning breast reconstruction as a critical component of post-cancer care.

Restraints in the Global Breast Reconstruction Market

The Global Breast Reconstruction market faces significant restraint due to the high costs associated with surgeries and advanced implants. Patients often encounter financial hurdles, as insurance coverage for reconstructive procedures is frequently limited or nonexistent, making it challenging for many to afford pre-operative consultations, surgical interventions, and post-operative care. This financial strain can lead to delayed procedures, adversely impacting market growth. Furthermore, regional economic disparities exacerbate access issues, restricting availability for lower-income populations and limiting the market's potential to expand into diverse socio-economic segments. Hence, the financial landscape serves as a formidable barrier to wider market penetration.

Market Trends of the Global Breast Reconstruction Market

The Global Breast Reconstruction market is witnessing a significant shift towards less invasive techniques, driven by advancements in surgical technologies and growing patient preferences for procedures that minimize recovery time and scarring. Techniques such as autologous fat grafting and endoscopic-assisted breast reconstruction are increasingly gaining popularity due to their aesthetic advantages, reduced post-operative discomfort, and quicker rehabilitation, enhancing overall patient satisfaction. As technology continues to evolve, these minimally invasive approaches are poised to reshape the future landscape of breast reconstruction, leading to improved outcomes and broader acceptance among both patients and healthcare professionals, ultimately pushing market growth.

Table of Contents

Introduction

  • Objectives of the Study
  • Definitions
  • Market Scope

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Market Overview Outlook
  • Supply Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Key Success Factor
  • Degree of Competition
  • Top Investment Pockets
  • Innovation Matrix
  • Ecosystem of the Market
  • Regulatory Landscape
  • Technology Analysis
  • Patent Analysis
  • PESTEL Analysis
  • Market Attractiveness Index, 2023

Breast Reconstruction Market, By Product

  • Market Overview
  • Breast Implant
    • Silicone Implants
    • Round
    • Anatomical
    • Saline Implants
    • Round
    • Anatomical
  • Tissue Expander
    • Saline Tissue Expander
    • Air Tissue Expander
  • Acellular Dermal Matrix

Breast Reconstruction Market, By Procedure

  • Market Overview
  • Immediate Procedures
  • Delayed Procedures
  • Revision Procedures

Breast Reconstruction Market, By Type

  • Market Overview
  • Unilateral Breast Reconstruction
  • Bilateral

Breast Reconstruction Market, By End User

  • Market Overview
  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Others

Breast Reconstruction Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2023

Key Company Profiles

  • Johnson & Johnson (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Allergan Aesthetics (AbbVie) (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ideal Implant Incorporated (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sebbin (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GC Aesthetics (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • POLYTECH Health & Aesthetics (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sientra (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Integra Lifesciences (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • RTI Surgical Holdings (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Establishment Labs S.A. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Silimed (Brazil)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Laboratories Arion (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Guangzhou Wanhe Plastic Materials Co. Ltd. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CEREPLAS (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • HansBiomed (South Korea)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PMT Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Shanghai Kangning Medical Device (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biodermis (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Surgiform Technology, Ltd. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Motiva Implants (Costa Rica)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments